Jw Pharmaceutical
Clinical trials sponsored by Jw Pharmaceutical, explained in plain language.
-
New pill aims to stop heavy periods caused by fibroids
Disease control Recruiting nowThis study is testing a new pill called KLH-2109 to see if it can safely reduce heavy menstrual bleeding in women who have uterine fibroids. About 254 participants will take either the new pill or a standard treatment for comparison. The main goal is to see if the new drug lowers…
Phase: PHASE3 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Two-in-One pill trial aims to tackle heart risk factors
Disease control Recruiting nowThis study is testing a new combination pill designed to treat two common conditions together: high blood pressure and high cholesterol. It will compare the combination pill to taking the medicines separately. The goal is to see if the single pill is effective at lowering blood p…
Phase: PHASE3 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New diabetes treatment study aims to smooth out blood sugar spikes
Disease control Recruiting nowThis study is testing a combination of diabetes medications to see if it helps control blood sugar levels more steadily throughout the day. It is for adults with type 2 diabetes whose current treatment with metformin and an SGLT-2 inhibitor isn't working well enough. Researchers …
Phase: PHASE4 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
First human test for new drug begins
Knowledge-focused Recruiting nowThis is the first study in people for a new drug called Epaminurad. It aims to see how the drug moves through the body and if it is safe. The study involves 34 healthy adult volunteers who will take a single dose while fasting.
Phase: PHASE1 • Sponsor: JW Pharmaceutical • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC